Opportunity
SAM #75F40126Q135718
Rat Brain Protein and Plasma Biomarker Analysis Services for FDA NCTR
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
August 03, 2026
Respond By
August 10, 2026
Identifier
75F40126Q135718
NAICS
541380, 541715
The U.S. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR), Division of Neurotoxicology, is soliciting scientific analysis services for rat brain and plasma samples. - Government Buyer: - U.S. Food and Drug Administration (FDA) - National Center for Toxicological Research (NCTR) - Division of Neurotoxicology - Services Requested: - Processing and ELISA assays for 288 rat brain tissue samples and 120 rat plasma samples - Quantification of the following biomarkers: - NMDA receptors - D1 dopamine receptors - D2 dopamine receptors - Mu opioid receptors - GFAP (Glial Fibrillary Acidic Protein) - Neurofilament light - Data delivery and assay validation updates required - Unique/Notable Requirements: - All results and supporting data must be delivered within 10 months of sample receipt - Firm-fixed price contract - Contractor must process and analyze both brain and plasma samples using validated ELISA methods - No specific OEMs or commercial vendors are named in the solicitation - The opportunity is focused on specialized neurobiological and biomarker quantification services
Description
See Attached Combined Synopsis/Solicitation 75F40126Q135718